Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1087753
Max Phase: Preclinical
Molecular Formula: C30H49NO2
Molecular Weight: 455.73
Molecule Type: Small molecule
Associated Items:
ID: ALA1087753
Max Phase: Preclinical
Molecular Formula: C30H49NO2
Molecular Weight: 455.73
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Betulin-28-Oxime
Synonyms from Alternative Forms(1):
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(/C=N/O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C30H49NO2/c1-19(2)20-10-15-30(18-31-33)17-16-28(6)21(25(20)30)8-9-23-27(5)13-12-24(32)26(3,4)22(27)11-14-29(23,28)7/h18,20-25,32-33H,1,8-17H2,2-7H3/b31-18+/t20-,21+,22-,23+,24-,25+,27-,28+,29+,30+/m0/s1
Standard InChI Key: GCYZHONUJBNDJH-UXEVJXGNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 455.73 | Molecular Weight (Monoisotopic): 455.3763 | AlogP: 7.46 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.82 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.31 | CX Basic pKa: 3.05 | CX LogP: 6.49 | CX LogD: 6.49 |
Aromatic Rings: 0 | Heavy Atoms: 33 | QED Weighted: 0.20 | Np Likeness Score: 3.00 |
1. Pohjala L, Alakurtti S, Ahola T, Yli-Kauhaluoma J, Tammela P.. (2009) Betulin-derived compounds as inhibitors of alphavirus replication., 72 (11): [PMID:19839605] [10.1021/np9003245] |
2. Alcazar W, López AS, Alakurtti S, Tuononen ML, Yli-Kauhaluoma J, Ponte-Sucre A.. (2014) Betulin derivatives impair Leishmania braziliensis viability and host-parasite interaction., 22 (21): [PMID:25240731] [10.1016/j.bmc.2014.08.023] |
3. Laavola M, Haavikko R, Hämäläinen M, Leppänen T, Nieminen R, Alakurtti S, Moreira VM, Yli-Kauhaluoma J, Moilanen E.. (2016) Betulin Derivatives Effectively Suppress Inflammation in Vitro and in Vivo., 79 (2): [PMID:26915998] [10.1021/acs.jnatprod.5b00709] |
4. Chen S, Zhang L, Chen Y, Fu L.. (2022) Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential., 65 (19.0): [PMID:36111355] [10.1021/acs.jmedchem.2c01097] |
Source(1):